Dysmenorrhea Market Size to Reach USD 20.0 Billion by 2035, Impelled by Advancements in Pain Management & Pharmaceuticals

March 04, 2025 | Healthcare

VIEW FULL TABLE OF CONTENTS

Dysmenorrhea Market Outlook 2025-2035:

The Dysmenorrhea market reached a value of USD 10.9 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 20.0 Billion by 2035, exhibiting a growth rate (CAGR) of 5.73% during 2025-2035. The dysmenorrhea treatment market is experiencing a dynamic shift, fueled by progress in both diagnostics and therapeutic interventions. The early and accurate diagnosis of dysmenorrhea is increasingly being made possible using modern technologies such as hormonal profiling and imaging through ultrasound, as well as AI menstrual health applications. All these give healthcare providers the ability to distinguish between primary and secondary dysmenorrhea, such that they can design tailored treatment strategies or may provide early intervention for improved patient journeys. It further transforms the therapeutic side of the dysmenorrhea management market with emerging new treatment options. Although conventional NSAIDs and hormones still play their parts, new options with non-hormonal medication have emerged to offer solutions with potentially lesser side effects. In addition, combining a pain reliever with a neuromodulation device or targeted hormonal treatments improves symptom control and makes pain relief and quality of life more bearable. These advancements are transforming dysmenorrhea management for millions worldwide.

Dysmenorrhea Market Outlook

To get more information on this market, Request Sample

Increasing Awareness & Diagnosis Rates

Greater increases in awareness and educational programs and initiatives concerning the subject of menstrual health empower many women to regard dysmenorrhea as a condition that can be treated rather than an unavoidable concomitant of their menstrual cycle. Government health agencies and NGOs seek to spread awareness of menstrual health through, among others, school programs, social media campaigns, and community workshops. This has, in turn, resulted in a rise in consultations with doctors, thus stimulating early intervention and better management of menstrual pain. Meanwhile, advances in diagnostics, like high-resolution ultrasound, MRI, and hormonal assessment, have provided opportunities to ascertain with accuracy underlying anomalies such as endometriosis, adenomyosis, and fibroids. The advent of many AI-driven menstrual tracking applications has given increasing power to the early diagnosis of dysmenorrhea via pain pattern monitoring and potential prediction of reproductive health disorders. Given the heightened awareness and precision in diagnostics, the number of women now receiving individualized treatment options has multiplied, therefore improving the quality of life and long-term health outcomes.

Increasing Adoption of Alternative & Non-Invasive Therapies

The ongoing trend among women is the preference for natural, noninvasive treatments for dysmenorrhea with fewer side effects, especially safer options. Herbal supplements, such as ginger, turmeric, and chasteberry, are in vogue because of their reputed anti-inflammatory and pain-relieving properties. Acupuncture and acupressure practices are under consideration for helping with hormonal balance and menstrual pain relief. Changes in dietary habits, which include increased intake of omega-3s and decreased consumption of caffeine, are more beneficial in assisting individuals with inflammation and cramps. Also, wearable devices for pain relief, such as transcutaneous electrical nerve stimulation (TENS) units, have been much sought after in assisting women with back pain through stimulation of nerves and better blood circulation without drugs. Yoga and meditation techniques focusing on reducing stress and relaxing muscles are now merging with a holistic approach toward dysmenorrhea management. With consumer awareness and technological development, the acceptance of alternative and noninvasive therapies is expected to expand further, offering more personalized and sustainable treatment for women.

Marketed Therapies in the Dysmenorrhea Market

Naprelan (Naproxen sodium) - Almatica Pharma

Naprelan (Naproxen Sodium), developed by Almatica Pharma, is a widely used extended-release NSAID for managing dysmenorrhea by reducing inflammation and relieving menstrual pain. Its long-acting formulation provides sustained pain relief, minimizing the need for frequent dosing.

Emerging Therapies in the Dysmenorrhea Market

DARE PDM1 - Dare Bioscience

DARE-PDM1, developed by Dare Bioscience, is an innovative, non-hormonal treatment in development for dysmenorrhea, aiming to provide effective and long-lasting pain relief. Designed as a novel, extended-release formulation, it targets menstrual pain by modulating prostaglandin activity, a key driver of uterine contractions.

Drug Name	Company Name	MOA	ROA
DARE PDM1	Dare Bioscience	Cyclooxygenase inhibitors	Oral

Detailed list of emerging therapies for dysmenorrhea provided in the final report…

Leading Companies in the dysmenorrhea Market:

The dysmenorrhea treatment market is undergoing a significant transformation, driven by competition and breakthrough innovations from leading pharmaceutical and biotech companies. Key players such as Almatica Pharma and Dare Bioscience are heavily investing in advanced pain management solutions, hormonal therapies, and non-invasive treatments to improve the management of menstrual pain. A major shift is occurring, moving beyond traditional NSAIDs and oral contraceptives toward disease-modifying treatments that specifically target uterine contractions, inflammation, and hormonal imbalances driving dysmenorrhea. This is evident in the development of novel therapies such as Naprelan (Naproxen Sodium), DARE-PDM1, and next-generation hormonal modulators, which aim to enhance treatment efficacy, reduce side effects, and provide long-lasting relief. Supported by ongoing clinical trials, innovative drug delivery systems, and digital health solutions, the dysmenorrhea treatment landscape is evolving toward personalized and effective therapies, offering hope for better pain control and improved quality of life for millions of affected women.

Key Players in the dysmenorrhea Market:

The key players in the dysmenorrhea market who are in different phases of developing different therapies are Almatica Pharma, Dare Bioscience, and others.

Key Players in the dysmenorrhea Market

Regional Analysis:

The dysmenorrhea treatment market is heavily concentrated in developed regions such as the United States, Germany, the UK, France, Italy, Spain, and Japan, where advancements in women’s health research and pain management therapies are driving innovation. The United States plays a pivotal role in this market due to its leadership in pharmaceutical R&D, digital health solutions, and non-invasive treatment technologies for menstrual pain. While current treatment approaches focus on NSAIDs, hormonal therapies, and lifestyle modifications, significant progress is being made in understanding the underlying causes of dysmenorrhea, leading to the development of targeted and non-hormonal therapies. The market is also being fueled by increased investments in women's health research, accelerated regulatory approvals for innovative pain management solutions, and strategic collaborations between pharmaceutical companies, research institutions, and healthcare providers. These efforts are expanding treatment options, improving menstrual health management, and ultimately enhancing quality of life for women affected by dysmenorrhea.

Key information covered in the report.

Base Year: 2024
Historical Period: 2019-2024
Market Forecast: 2025-2035

Countries Covered

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the dysmenorrhea market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the dysmenorrhea market
Reimbursement scenario in the market
In-market and pipeline drugs

Competitive Landscape:

This report offers a comprehensive analysis of current dysmenorrhea-marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. Across the six major continents and 100+ countries, we work alongside our business partners as one team with a common ambition to achieve unparallelled results, gain a competitive edge, and transform industries. IMARC Group excels in understanding its clients’ business priorities and delivering tailored solutions that drive meaningful outcomes. Our client base spans over 3,000 organizations in the private, public, and social sectors, ranging from high-growth startups to Fortune 500 companies.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Phone Number: - +1 631 791 1145, +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Dysmenorrhea Market Size to Reach USD 20.0 Billion by 2035, Impelled by Advancements in Pain Management & Pharmaceuticals

Purchase Options Discount
Offer

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.